XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.31

+1.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (14566)	9/15/2000 2:48:16 PM
From: Cacaito	Read Replies (2) of 17367

Blaming the fda AGAIN!!! xoma knew this, it was xoma responsibility, even here in the thread non sophisticated poster brought the argument of low percentage mortality, the two arms of the study was designed to address that. What happened to the "two arms" I have not seen anybody talking about the different groups (maybe manfred did). The underpowered characteristics of the study was known. What are you blamind the fda for? And SubpartE is not for approval of lack of efficacy drugs. And the P for less amputations was 0.06, even for this aspect of the study one needs thousands of patients to definitely prove if the trend is indeed true.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next